Cytek Biosciences, Inc. (CTKB) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $119.80M | +15.5% |
| 2024 | $103.76M | +2.3% |
| 2023 | $101.39M | +7.9% |
| 2022 | $93.93M | +62.2% |
| 2021 | $57.92M | +38.9% |
| 2020 | $41.69M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $119.80M | +15.5% |
| 2024 | $103.76M | +2.3% |
| 2023 | $101.39M | +7.9% |
| 2022 | $93.93M | +62.2% |
| 2021 | $57.92M | +38.9% |
| 2020 | $41.69M | — |